Connect with us


Studies Shows How Hemp Oil is Helping With Chronic Pain Relief



Recent studies conducted on the many benefits of Cannabinoid reveal that the product can relieve a broad range of medical problems, and even patients’ feedback are in support of the same data. Sally Woods of Ohio expressed that she has been using cannabinoid, two drops under her tongue daily, for the preceding three months and has experienced a drop in pain, more energy and an uplifted mood. She suffers from chronic lyme with osteoarthritis in all her joints.

Another patient, James Bolton from Michigan stated that he has been using cannabis extracts from past few years. The cannabis extracts have not cured his conditions, but had definitely made the disease bearable. Bolton has been reported suffering from anxiety and fibromyalgia. Like these two instances, there are numerous positive stories that highlight the healing properties of Cannabinoid. So, let us examine the many benefits behind cannabinoid and the studies supporting the same.

Cannabinoid and Endocannabinoid system

The next big cannabis story to hit North America is Phoenix Life Science International (PLSI), traded in the US, but with the largest global production based in the tropics and a license to distribute worldwide. Take a look at Phoenix Life Science International PLSI), Its currently trading under $18 dollars per share on the OTC markets. Learn More Now!

Marijuana has been classified as a Schedule I drug. During the late 30s, it was marked as a substance, or chemical with no permitted medical application by the Federal Government. Since then, there has been some minor change in people’s perception, with recent polls indicating over 53% in its favor while 77% of the people in the U.S. supporting it for medical usage. This change in perception along with the changing laws in numerous states prompted scientists to go ahead and plan studies on the different medical uses of cannabinoids.

During the 90s, scientists learned about the Endocannabinoid system that contains different receptors throughout a person’s brain and nervous system. The system together with receptors helps to regulate human body, from motor function to the sensation of pain. The studies have shown that Cannabinoid in the cannabis crop interact with these receptors and helps bring in the positive result.

Cannabinoid can ease chronic pain

In 2003, the clinical rehabilitation released a study demonstrating that pain relief associated with cannabinoid and THC and Hemp was comparatively lower among subjects who took placebo. The same results were supported by another study in 2008 conducted by Dr. Ethan Budd Russo that indicated that Hemp could help treat and manage pain.

Latest data by the NASEM showed that cannabinoids or cannabis can help considerably in the treatment of chronic pain. The data revealed that both cannabinoid compounds and inhaled marijuana work for pain.

Different studies and patients’ feedback show that cannabinoid is a good treatment option for pain. However, marijuana is still classified under the Schedule 1 list of drugs, which always create some doubt on the usage of marijuana for medicinal purposes. More research should be done to know the relation between Cannabinoid and its impact on Endocannabinoid System, so that more and more people can use it to help cure their pain associated with different medical problems.

Some of the top brands include Greenleaf Farms, MedijaneRX and Phoenix Life Brands.


Pushing the barriers for global distribution, Phoenix Life Science International (PLSI) is the next cannabis play. Just think Canopy x 100, that is how big their plantation in the tropics will be. No lights, no green houses, just maximum growth + minimal cost = home run. Learn More Now!


Learn More About PLSI at your brokerage today!

Continue Reading



Auxly Cannabis Group Inc (OTCMKTS:CBWTF) Acquires 46% Stake In Curative Cannabis And Agrees to Fund Cannabis Cultivation Facility To Produce Ultra Premium Cannabis

Auxly Cannabis Group Inc (OTCMKTS:CBWTF) has entered a deal to take over a 46% stake in Curative Cannabis. The company...


Canntrust Holdings Inc. (OTCMKTS:CNTTF) Receive Permission From The Town Of Pelham For Their Third Phase Construction

CannTrust Holdings Inc. (OTCMKTS:CNTTF) has announced that they have obtained the required permit to go on with the third phase...


Indiva Ltd (OTCMKTS:NDVAF) Announces 9.9% Equity Investment In Retailgo Inc.

Indiva Ltd (OTCMKTS:NDVAF) has announced that they are delighted to have finalized an Equity investment of 9.9% in RetailGo Inc....


Future Farm Technologies Inc (OTCMKTS:FFRMF) Plans To Begin Selling Of Cheery Wine Strain Hemp Seeds And Test Operation Of The Oil Extraction Equipment

Future Farm Technologies Inc (OTCMKTS:FFRMF) is planning to commence the selling of the elite cherry Wine hemp seeds by putting...


OrganiGram Holdings Inc (OTCMKTS:OGRMF) Sources Hemp With High Levels of CBD From 1812 Hemp

OrganiGram Holdings Inc (OTCMKTS:OGRMF) has entered into a supply pact with 1812 Hemp, an industrial hemp research company based in...


Kona Gold Solutions Inc (OTCMKTS:KGKG) Declares That They Have Acquired Gold Leaf Distribution

Kona Gold Solutions Inc (OTCMKTS:KGKG) has announced the acquisition of Gold Leaf distribution a newly established distribution company. The Florida...


CFN Media Group features Supreme Cannabis Company (OTCMKTS:SPRWF) as consideration for investors as their 2019 stock scales up

CFNB Media Group has announced a publication on Supreme Cannabis Company (OTCMKTS:SPRWF) as a licensed producer obsessed with quality. Supreme...


Village Farms International Inc (OTCMKTS:VFFIF) Leading Greenhouse Crop Protection And Announces Plans To List Its Common Shares On The NASDAQ Market

Village Farms International Inc (OTCMKTS:VFFIF) has announced that they have facilitated Health Canada Pest Management Agency to get approval for...


Sunniva Inc. (OTCMKTS:SNNVF) Secures More Funding For Growth Strategy As Plans Solidify Towards A Tremendous Year

Sunniva Inc. (OTCMKTS:SNNVF) is solidifying its growth strategy in anticipation for exponential growth this year. Notably, the firm acquired a...


Curis, Inc. (NASDAQ:CRIS) Announce The Dosing Of The First Mesothelioma Patient In The First Phase Of The CA-170 Study

Curis, Inc. (NASDAQ:CRIS) has announced the enrolment and dosing of the first mesothelioma patient in the first phase of the...


Create a future where the human body can repair, restore, and rejuvenate itself


Trading Symbol


The Next Big Global Cannabis Play